\-\ Texto\\:\\ \ \(0\)\
\-\ sonographic\\ image\\ of\\ the\\ spleen\\ demonstrates\\ multiple\\ well\\-defined\\,\\ hyperechoic\\ lesions\\ within\\ the\\ splenic\\ parenchyma\\ with\\ a\\ similar\\ appearance\\ to\\ hepatic\\ hemangiomas\\.\ \(0\)\
\-\ splenic\\ hemangioma\ \(0\)\
\-\ hemangioma\\,\\ hamartoma\\,\\ angiosarcoma\\,\\ lymphoma\\,\\ metastatic\\ disease\\,\\ malignant\\ histiocytoma\\,\\ infection\\,\\ post\\-traumatic\\ hematomas\\,\\ lymphangiomas\ \(0\)\
\-\ 36\\ yo\\ female\\ with\\ persistant\\,\\ intermittent\\ left\\ shoulder\\ pain\\ \\(no\\ \ \(1\)\
\-\ injury\\)\\ x\\ 4\\ weeks\\.\\ pain\\ is\\ often\\ severe\\.\\ there\\ is\\ a\\ clinical\\ question\\ of\\ referred\\ pain\\.\\ the\\ patient\\ also\\ has\\ a\\ history\\ of\\ splenic\\ pathology\\ on\\ past\\ imaging\\ studies\\.\\ please\\ evaluate\\ spleen\\ and\\ gallbladder\\.\ \(0\)\
\-\ hemangiomas\\ are\\ benign\\ vascular\\ neoplasms\\ with\\ slow\\ internal\\ flow\\.\\ \\ \\ they\\ are\\ the\\ most\\ common\\ benign\\ neoplasms\\ of\\ the\\ spleen\\,\\ are\\ almost\\ always\\ asymptomatic\\ and\\,\\ as\\ in\\ this\\ case\\,\\ are\\ found\\ incidentally\\ on\\ imaging\\.\\ \\ \\ \\ hemangiomas\\ have\\ been\\ reported\\ in\\ up\\ to\\ 14\\%\\ of\\ autopsy\\ specimens\\.\\ \\ they\\ are\\ usually\\ a\\ solitary\\ solid\\ mass\\;\\ although\\,\\ they\\ can\\ be\\ diffuse\\ and\\ rarely\\ can\\ cause\\ splenomegaly\\.\\ \\ this\\ entity\\ has\\ also\\ been\\ described\\ in\\ the\\ klippel\\-trenaunay\\-weber\\ syndrome\\.\\ \\ they\\ do\\ not\\ usually\\ calcify\\.\\ \\ hamartomas\\,\\ also\\ benign\\ splenic\\ lesions\\ but\\ less\\ common\\,\\ may\\ demonstrate\\ some\\ calcification\\.\\ \\ distinguishing\\ between\\ these\\ two\\ benign\\ entities\\ is\\ often\\ difficult\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ splenic\\:\\ 0\\.33156515380923296\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.2769349961716508\ \(0\)\
\-\ spleen\\:\\ 0\\.2467554440569214\ \(0\)\
\-\ they\\:\\ 0\\.24149023140162984\ \(0\)\
\-\ benign\\:\\ 0\\.23216679933274695\ \(0\)\
\-\ are\\:\\ 0\\.16030821929013725\ \(0\)\
\-\ neoplasms\\:\\ 0\\.15747881335891636\ \(0\)\
\-\ hemangioma\\:\\ 0\\.1421490959875826\ \(0\)\
\-\ lymphangiomas\\:\\ 0\\.12485734043953983\ \(0\)\
\-\ also\\:\\ 0\\.11923071884032012\ \(0\)\
\-\ persistant\\:\\ 0\\.11128508172844777\ \(0\)\
\-\ often\\:\\ 0\\.11026470621084372\ \(0\)\
\-\ usually\\:\\ 0\\.1063842523124279\ \(0\)\
\-\ hamartomas\\:\\ 0\\.1043233057010641\ \(0\)\
\-\ autopsy\\:\\ 0\\.10342532319078399\ \(0\)\
\-\ specimens\\:\\ 0\\.10257868275978811\ \(0\)\
\-\ distinguishing\\:\\ 0\\.10257868275978811\ \(0\)\
\-\ calcify\\:\\ 0\\.10177782961422685\ \(0\)\
\-\ the\\:\\ 0\\.10115773065261875\ \(0\)\
\-\ entities\\:\\ 0\\.1010180643592099\ \(0\)\
\-\ angiosarcoma\\:\\ 0\\.10029537590713994\ \(0\)\
\-\ been\\:\\ 0\\.09845436463695062\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.09831748554580717\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.0977128230173557\ \(0\)\
\-\ lesions\\:\\ 0\\.0970517665851349\ \(0\)\
\-\ common\\:\\ 0\\.09583559275925296\ \(0\)\
\-\ hematomas\\:\\ 0\\.09405628833182623\ \(0\)\
\-\ entity\\:\\ 0\\.09190582698886848\ \(0\)\
\-\ pain\\:\\ 0\\.09070522660920845\ \(0\)\
\-\ imaging\\:\\ 0\\.08880895067587218\ \(0\)\
\-\ can\\:\\ 0\\.08867958649612345\ \(0\)\
\-\ question\\:\\ 0\\.08715248566628918\ \(0\)\
\-\ hamartoma\\:\\ 0\\.08311073209623955\ \(0\)\
\-\ of\\:\\ 0\\.08267554418583782\ \(0\)\
\-\ slow\\:\\ 0\\.0814399854928609\ \(0\)\
\-\ always\\:\\ 0\\.07976134116866421\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.07778345080733146\ \(0\)\
\-\ solitary\\:\\ 0\\.07732765561278618\ \(0\)\
\-\ has\\:\\ 0\\.07718882729854393\ \(0\)\
\-\ sonographic\\:\\ 0\\.07603882786605545\ \(0\)\
\-\ almost\\:\\ 0\\.0759023091573274\ \(0\)\
\-\ gallbladder\\:\\ 0\\.07550014395468327\ \(0\)\
\-\ rarely\\:\\ 0\\.07536847930958815\ \(0\)\
\-\ incidentally\\:\\ 0\\.0719847973164026\ \(0\)\
\-\ please\\:\\ 0\\.07087964814179439\ \(0\)\
\-\ difficult\\:\\ 0\\.07012472425797375\ \(0\)\
\-\ do\\:\\ 0\\.07003300771079853\ \(0\)\
\-\ 36\\:\\ 0\\.06994185557671778\ \(0\)\
\-\ is\\:\\ 0\\.06941779735262195\ \(0\)\
\-\ intermittent\\:\\ 0\\.06905991803104318\ \(0\)\
\-\ parenchyma\\:\\ 0\\.06863789019449137\ \(0\)\
\-\ described\\:\\ 0\\.06855490860466706\ \(0\)\
\-\ hepatic\\:\\ 0\\.06728678271321856\ \(0\)\
\-\ pathology\\:\\ 0\\.06633082684109183\ \(0\)\
\-\ evaluate\\:\\ 0\\.06570339386227854\ \(0\)\
\-\ shoulder\\:\\ 0\\.06563529178808954\ \(0\)\
\-\ solid\\:\\ 0\\.06477733139090014\ \(0\)\
\-\ similar\\:\\ 0\\.06439751122011919\ \(0\)\
\-\ 14\\:\\ 0\\.06308266524248764\ \(0\)\
\-\ in\\:\\ 0\\.06305812185815826\ \(0\)\
\-\ referred\\:\\ 0\\.06252153090649701\ \(0\)\
\-\ studies\\:\\ 0\\.06198088055966978\ \(0\)\
\-\ reported\\:\\ 0\\.06085665894502504\ \(0\)\
\-\ calcification\\:\\ 0\\.06032500668583491\ \(0\)\
\-\ malignant\\:\\ 0\\.060230359877904434\ \(0\)\
\-\ this\\:\\ 0\\.05806734469621083\ \(0\)\
\-\ cause\\:\\ 0\\.05756126285115265\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.05752192106164107\ \(0\)\
\-\ although\\:\\ 0\\.05752192106164107\ \(0\)\
\-\ less\\:\\ 0\\.05748268348891249\ \(0\)\
\-\ internal\\:\\ 0\\.056943999577540295\ \(0\)\
\-\ flow\\:\\ 0\\.056279002240438754\ \(0\)\
\-\ vascular\\:\\ 0\\.055781664273688754\ \(0\)\
\-\ injury\\:\\ 0\\.05509895472589795\ \(0\)\
\-\ past\\:\\ 0\\.054999209062480535\ \(0\)\
\-\ between\\:\\ 0\\.05490013059912824\ \(0\)\
\-\ found\\:\\ 0\\.05467149270717395\ \(0\)\
\-\ image\\:\\ 0\\.054037041332412765\ \(0\)\
\-\ clinical\\:\\ 0\\.05354834793438174\ \(0\)\
\-\ severe\\:\\ 0\\.05348837953245625\ \(0\)\
\-\ some\\:\\ 0\\.05316282411887694\ \(0\)\
\-\ diffuse\\:\\ 0\\.05298821885487477\ \(0\)\
\-\ yo\\:\\ 0\\.052787080506548394\ \(0\)\
\-\ and\\:\\ 0\\.052378974185946434\ \(0\)\
\-\ infection\\:\\ 0\\.05103928681174572\ \(0\)\
\-\ on\\:\\ 0\\.051037298317204605\ \(0\)\
\-\ appearance\\:\\ 0\\.05093817942228337\ \(0\)\
\-\ syndrome\\:\\ 0\\.05093817942228337\ \(0\)\
\-\ weeks\\:\\ 0\\.0506389333851473\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05032143025501899\ \(0\)\
\-\ two\\:\\ 0\\.05017715468212103\ \(0\)\
\-\ with\\:\\ 0\\.04963496568227302\ \(0\)\
\-\ these\\:\\ 0\\.047713768704174285\ \(0\)\
\-\ metastatic\\:\\ 0\\.046340751944602694\ \(0\)\
\-\ most\\:\\ 0\\.04397325488281572\ \(0\)\
\-\ demonstrate\\:\\ 0\\.043926107336239674\ \(0\)\
\-\ may\\:\\ 0\\.04252006313731053\ \(0\)\
\-\ demonstrates\\:\\ 0\\.042448884840594496\ \(0\)\
\-\ case\\:\\ 0\\.042448884840594496\ \(0\)\
\-\ to\\:\\ 0\\.04224668600646678\ \(0\)\
\-\ have\\:\\ 0\\.042209405562596676\ \(0\)\
\-\ up\\:\\ 0\\.0417960157077596\ \(0\)\
\-\ but\\:\\ 0\\.04178243278608946\ \(0\)\
\-\ multiple\\:\\ 0\\.041327871888036175\ \(0\)\
\-\ female\\:\\ 0\\.04077226944250786\ \(0\)\
\-\ within\\:\\ 0\\.03891534744138946\ \(0\)\
\-\ disease\\:\\ 0\\.0354675945969053\ \(0\)\
\-\ be\\:\\ 0\\.0342758524768431\ \(0\)\
\-\ as\\:\\ 0\\.03394425294629177\ \(0\)\
\-\ there\\:\\ 0\\.033619914659735024\ \(0\)\
\-\ not\\:\\ 0\\.03335623547085725\ \(0\)\
\-\ history\\:\\ 0\\.03228161313477405\ \(0\)\
\-\ mass\\:\\ 0\\.03227446612617057\ \(0\)\
\-\ left\\:\\ 0\\.02882275846063454\ \(0\)\
\-\ patient\\:\\ 0\\.027481668181584075\ \(0\)\
\-\ no\\:\\ 0\\.02747649904000542\ \(0\)\
